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Introduction: The main problems of autogenous bone transplants are their unpredictable atrophy and their loss of
structure. One key factor lies in the poor revascularization of simple onlay grafts. The the aim of this study was to
evaluate the revascularization processes in autogenous bone grafts from the iliac crest to the alveolar ridge.
Methods: In a sheep model, autogenous bone grafts were harvested from the iliac crest. A combination of a
resorbable collagen membrane (CM) and deproteinized bovine bone material (DBBM) was used to modify the bone
graft (experiment 2). This was compared with a simple onlay bone graft (control group, experiment 1). The amount
of vessels in bone and connective tissue (CT), and the amount of CT were analyzed. The expression of von
Willebrand factor (vWF) was compared between the two experimental groups using immunohistochemical analysis.
Results: The ratio of the amount of vessels in bone and CT changed over time, and more vessels could be
detected in bone at 12–16 weeks of graft healing. The number of vessels were significantly higher in experiment 2
than in experiment 1. More CT was found in experiment 1, whereas the amount of CT in both experiments
decreased over time.
Conclusion: This study shows a more intensive and extensive revascularization in experiment 2, as significantly
more vessels were detected. The decreased amount of CT in experiment 2 clarifies its clinical superiority.
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Bone grafting is among the most frequently performed
procedures with in oral surgery. Contiguous to their use
in reconstruction of defects after tumor, trauma, or in-
fections, bone transplants are also used for correcting
syndromic defects and to create an adequate bone vol-
ume before the placement of dental implants. The re-
placement of bone as a support of the surrounding soft
tissue is essential to ensure the functional and aesthetic
rehabilitation of the patient. The gold standard is the
transplantation of autogenous bone, which has the abil-
ity to maintain its osteogenic potential [1,2]. However,* Correspondence: steffen.koerdt@web.de
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reproduction in any medium, provided the orthe main problems of autogenous bone transplants are
their unpredictable atrophy and their loss of structure
[3,4]. A decrease in the volume of nonfixed grafts of up
to 50%-70% has been reported to occur during the first
year after transplantation [5,6]. The size of the defect is
a predetermined factor essential for the successful in-
corporation of a bone transplant. Adequate stabilization
of the defect and the quality of the transplant as well as
of the host site are considered key factors for a success-
ful transplant healing. The quality of the host site can
either be influenced by using anti-inflammatory medica-
tion or surgically through the concept of guided tissue
regeneration (GTR), the use of bone substitution mater-
ial, rigid fixation of the graft and inhibition of osteo-
clastic activities [5-14].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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desired cells from migrating into a defect using different
kinds of barrier membranes. On the other hand, this al-
lows certain desired cells to proliferate in the wound
[15]. This concept was later employed in bone regener-
ation (guided bone regeneration, GBR) [16-20]. How-
ever, in clinical use, GBR does not always result in a
predictable bone fill of the defect [17,20]. In experimen-
tal studies as well as in clinical use, a successful combin-
ation of onlay bone grafts with deproteinized bovine
bone material (DBBM) has been reported [5,8]. Previous
studies also showed the superiority of a combination of
DBBM and GBR with the use of collagen membrane
(CM). This current study adopts the results of Adeyemo
et al. and attempts to put an emphasis on the revascular-
ization procedures within the graft in the same
experimental setting [3,4,21]. DBBMs in general, are
considered to be biocompatible and osteoconductive;
however, evidence about their biodegradability remains
inconclusive [22,23].
One crucial factor for the successful incorporation of a
transplant is its revascularization, as nutrients, gas, and
undifferentiated mesenchymal cells are transported into
the defect and bone regeneration through newly formed
vessels is promoted [24,25]. Several studies described a
close relation between new bone formation and revascu-
larization [26,27]. Schmid et al. described, in a rabbit
animal model, the close relation between the use of GBR
and de novo extraskeletal bone formation when consid-
ering the effects of angiogenesis [25].
Only few reports on revascularization in bone grafts
with and without GBR and DBBM are found in the lit-
erature. The aim of this study was to evaluate the differ-
ent aspects of revascularization within the host site and
the graft in a sheep model.
Material and methods
Twelve adult female sheep were used in this study (mean
weight ± standard deviation [SD], 73.6 ± 8.6 kg; range.
63–90 kg). The medical ethics committee of the Univer-
sity of Cologne, Germany, and local authorities approved
the research reported in this article (institutional review
board registration no 50.203.2 K43, 36/01). Depending
on the time of euthanasia, the animals were randomized
into four groups of three animals each.
Anesthesia
After general anesthesia induction with 2% intravenous
propofol, each animal was intubated. Anesthesia was
maintained during the surgical procedure with (1)
isoflurane, (2) oxygen, (3) propofol (2%), and (4)
midazolam. In all animals, a perioperative antibiotic
prophylaxis with penicillin-dihydrostreptomycin (aniMe-
dica, Germany) was used for at least 3 days postope-ratively. The animals also received analgesic treatment
(Rimadyl; Pfizer, Germany) for 3 days after surgery, for
pain management. At the end of surgery, anesthesia was
terminated by the gradual wearing off of the effect of
2% propofol.
Harvesting and transplantation of Iliac bone graft
All experimental procedures were performed by one of
the investigators following a standardized protocol.
Under general anesthesia, for all experiments performed,
a bicortical bone graft (2.0 × 2.0 × 1.5 cm) was harvested
from the iliac bone of each sheep. The harvested corti-
cocancellous graft was divided into two equal sizes
(1.0 × 2.0 × 1.5 cm), followed by splitting into two mono-
cortical grafts each (1.0 × 2.0 × 0.75 cm, Figure 1). For all
experiments the lateral surface of the mandible was
carefully exposed through an extraoral surgical approach
without perforation to the oral cavity in order to avoid
excessive damage to the internal structures of the man-
dible (Figure 1). Each sheep received the experimental
grafts on the lateral surface of the mandible (Figure 1).
Surgical wounds were then closed in layers with
interrupted resorbable sutures (Vicryl® 2.0; Ethicon,
Norderstedt, Germany). All procedures performed in a
strictly aseptic environment.
Experiment 1
The cancellous bone portion of the graft was placed
tightly against the mandibular cortical bone and fixed
with two titanium screws. The screws were inserted into
the graft until the undersurface of the screw heads came
into contact with the outer surface of the graft.
Experiment 2
The cancellous bone portion of the graft was placed
tightly against the mandibular cortical bone and fixed
with two titanium screws. In addition, Bio-Oss® spongi-
osa granules (0.25 − 1.0 mm) (Geistlich Pharma AG,
Switzerland), moistened with blood, were applied around
the graft and contoured well. The recipient site and the
graft covered with Bio-Oss® were then covered with a
Bio-Gide® CM (Geistlich Pharma AG, Switzerland) fixed
in place with microscrews.
Harvesting and preparation of the specimens
Under general anesthesia, three sheep each were killed
at 4, 8, 12, or 16 weeks after grafting by using an
overdose (40 mL) of Narcoren (Merial, Germany). In
addition, 6–7 mL of heparin sodium (Aventis, Germany)
was injected intravenously to prevent blood coagulation
after death. The grafts were exposed and harvested en
bloc. Specimens consisted of the (1) bone graft, (2)
overlying soft tissue, and (3) the underlying mandibular
cortical bone. The formalin-fixed specimens were
Figure 1 Intraoperative situs: (a) Sheep were intubated and shaved preoperatively. (b) Exposed lateral surface of the mandible before
transplantation. (c) Monocortical bone grafts. (d) From left to right: experiment 1, experiment 2, and negative control with a non-porous
silicone membrane.
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on the volume of the specimen. After dehydration the
specimens were embedded in paraffin wax. For analysis,
10 − μm sections were cut from the paraffin-embedded
tissue samples. (Microtome Leica RM 2255).
Immunohistochemical staining was performed according
to local standard protocols. The specimens were deparaffi-
nized in xylene and rehydrated in a graded alcohol series.
After washing with 0.05 M Tris-buffered saline (TBS) and
treatment of the specimens with CH3OH and H2O2, to
block endogenous peroxidase and to avoid false-positive
results, the samples were treated with ammonium chlorideFigure 2 Photomicrograph of an unstained specimen illustrating theand Triton X (Schwarz/Mann Biotech, USA) in TBS to in-
crease the permeability of the cell walls. Incubation with
5% bovine serum antibody (PAA Laboratories, UK) was
followed by treatment with a primary antibody at a pre-
tested concentration (1:200). After incubation with the
primary antibody for 24 h at 4°C, incubation with the
secondary antibody for 60 min, and washing with TBS,
streptavidin biotinylated horseradish peroxidase complex
(Amersham Biosciences, Germany) was added. For color
development, a diaminobenzidine solution (Sigma-Aldrich,
USA) was used. Color development was monitored and
standardized for all stainings with the specific antibody.different regions of interest (ROI). (magnification, 16×).
Koerdt et al. Head & Face Medicine 2013, 9:40 Page 4 of 9
http://www.head-face-med.com/content/9/1/40The specimens were photographed under magnification
(Leitz DM RBE/RD [Leica], Camedia C-4040Zoom [Olym-
pus]) and divided into certain regions of interest (ROI) −
(1) bone graft, (2) recipient site, and (3) transfer zone − that
were used for the analysis. Figure 2 shows the different
ROIs within an unstained histological photomicrograph.
All photomicrographs were closely studied and (1) os-
teocytes (OCy), (2) osteoblasts (OB), and (3) osteoclasts
(OC) were identified as shown in Figure 3.
To illustrate the revascularization processes vessels in
connective tissue (CT) and bone were analyzed in the ROI
“bone graft”. Moreover, the amount of CT was evaluated.
High-power fields with 200× magnification were used for
analysis. The density of vessels in CT and bone was
assessed using a three-level scale: 0 = none, 1 = weak,
2 =moderate, and 3 = strong/dense. The amount of CT
was analyzed according to the scale mentioned above.
The positivity (POS) of the immunostaining was
assessed using a three-level scale in which negative to 0
indicated 0–5% positive cells, 1 indicated >5–20% posi-
tive cells, 2 indicated >20–50% positive cells, and 3
indicated >50–100% positive cells. Intensity (I) was
graded as follows: 0 = none, + = weak, ++ =moderate,
and +++ = strong/intense. For all mean values, the
immunoreactive score was calculated as follows: IRS =
[(IInvestigator1 + IInvestigator2)/2] × [(POSInvestigator1 + POSInves-
tigator2)/2]; minimum value = 0; maximum value = 9 [28].
All specimens were evaluated by two independent and
specially trained investigators (S.K. and J.S.) who were
blinded at the time of analysis.
Data analysis
Because of the small sample size, specimens from 4 and
8 weeks after augmentation were classified as measure-Figure 3 Photomicrograph analyzing the different types of cells with
osteoblast. (mangnification, 200×).ment 1 (M1) samples; all specimens from 12 and
16 weeks after the operation were classified as measure-
ment (M2) samples.
All data were analyzed using SPSS for Mac (version
17.0; SPSS, Chicago, IL, USA). Means and SDs were
calculated, and tests of significance were performed.
For normally distributed values, the t-test was per-
formed. For values non-normally distributed values the
Mann–Whitney-test was used. Before the t-test, the
Levene´s test was used to assess the equality of the sam-
ples. The statistical significance was adapted to multiple
testing. Statistical significance was defined as α = 0.05.
Results
In experiment 2, infection occured in two animals dur-
ing measurement 1. These were not included in the
analysis.
Vessels in CT and bone
Overall, the amount of vessels in the two experimental
groups was at a similar level during measurement 1.
Table 1 summarizes the findings after 4–8 weeks of graft
healing. Considering the two measurements over time,
the amount of vessels in experimental group 1 de-
creased, whereas it stayed almost constant in experiment
2 with GBR and DBBM as described in Table 2.
4–8 weeks after transplantation of the bone graft more
vessels could be found in CT than in bone. At measure-
ment 2, after a postoperative period of 12–16 weeks, this
situation changed and more vessels were detected in
bone. Figure 4 shows the amount of vessels in CT and
bone according to the different measurements over time
and experimental groups. In statistical analysis the differ-
ence between the amounts of vessels in CT inin the ROI “bone graft”. OCy, osteocyte; OC, osteoclast; OB,
Table 1 Mean values and standard deviations of the three-level score evaluating the amount of vessels in connective
tissue (CT) and bone at measurement 1
Experiment Na Mean Standard-deviation
Number of vessels in bone 1 93 1.457 0.758
2 23 1.565 0.870
Number of vessels in connective tissue 1 94 1.360 0.571
2 23 1.332 0.534
aN = number of specimens.
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cant (1.46 ± 0.76 vs. 0.69 ± 0.65; p < 0.001). The amount
of vessels in bone in experiment 2 at both measurements
was increased (1.75 ± 0.60 vs. 1.33 ± 0.53; p < 0.05).
After 12–16 weeks of incorporation of the bone grafts,
vessels were statistically significantly increased in CT
and bone (0.69 ± 0.65 vs. 1.10 ± 0.74; 1.75 ± 0.60 vs.
1.40 ± 0.65; all p < 0.05).
Amount of CT
The combination of GBR and the use of DBBM in bone
transplants as in experiment 2 showed, at both measure-
ments, a lower rate of CT within the bone graft com-
pared with experiment 1 (simple onlay bone graft). This
difference was not statistically significant at any meas-
urement (2.63 ± 0.56 vs. 2.52 ± 0.54; 2.08 ± 0.67 vs.
1.98 ± 0.67; all p > 0.05). In both experimental groups, a
decreasing amount of CT over time was observed, as
shown in Figure 5. The descriptive statistics can be
found in Table 3. The increased amount of CT in simple
onlay bone grafts at measurement 1 compared with
measurement 2 is statistically highly significant (2.52 ±
0.54 vs. 1.98 ± 0.67; p < 0.001). The decreased expression
of CT over time in experiment 2 also shows statistical
significance in data analysis (2.62 ± 0.56 vs. 2.08 ± 0.67;
p < 0.05).
Immunohistochemical staining for vWF
Figure 6 shows the expression of vWF for experiments 1
and 2. An increased expression could be observed within
the ROI “recipient site” (4.32 ± 2.71 vs. 3.06 ± 2.11;
p = 0.79). Taking the two measurements over time into
consideration, both experimental groups showed a statis-
tically significantly higher expression at M1 (3.96 ± 2.46Table 2 Mean values and standard deviations of the three-lev
tissue (CT) and bone at measurement 2
Experiment
Number of vessels in bone 1
2
Number of vessels in connective tissue 1
2
aN = number of specimens.vs. 2.84 ± 2.14; p < 0.05). Experiment 1 shows a higher
overall expression of vWF than experimental group 2
(3.68 ± 2.44 vs. 2.74 ± 1.96; p = 0.22).
Discussion
The unpredictable resorption and structural loss of in-
tegrity of simple onlay bone grafts in alveolar ridge aug-
mentation procedures is still a limiting factor in their
clinical use [8-12,29-31]. Resorption occurs especially
within the first year after transplantation [32]. For pe-
riods from 6 to 18 months after the procedure, a loss in
strength from up to 33% in cortical bone grafts is re-
ported [33].
De Marco and colleagues conducted a study in rats
that compared bone grafts covered with an expanded
polytetrafluoroethylene (e-PTFE) membrane and simple
autogenous onlay grafts [30]. Histomorphologic analysis
was done 3, 7, 14, and 21 days after surgery. Revasculari-
zation occurred in both experimental groups, although
the authors were able to show that vascular sprouts en-
tered the graft from the host side as well as from the
surrounding CT in the experimental group with the e-
PTFE membrane covered graft.
Adeyemo et al. were able to show the clinical advan-
tages of the use of DBBM in combination with GBR [4].
They illustrated that recipient bed perforation did not
show any advantage over nonperforation; however, they
reported that retention of the overlying periosteum re-
sulted in better volume maintenance of the bone graft [3].
The present study compared autogenous bone grafts—
simple onlay grafts to the mandible and onlay bone
grafts combined with GBR and DBBM—with special at-
tention to revascularization, by means of histomorpholo-






Figure 4 Graphic illustration of the three-level score for evaluating the amount of vessels within bone and connective tissue (CT)
according to the different experiments and measurements.
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dures results in reduced resorption, less atrophy and
better incorporation of the bone graft [7,10-12,34,35].
The concept of GTR/GBR is based on the assumption
that cells migrate into a defect at different rates:
epithelial and connective tissue both migrate at a faster
rate, whereas bone-forming cells migrate at a slower
rate. GTR/GBR adopts this concept and regulates theFigure 5 Graphic illustration of the three-level score for evaluating th
experiments and measurements.proliferation of different cell types within the graft by
means of membranes, preventing fast migrating cells
from entering the defect area and allowing the slower
migrating bone-forming cells to multiply [10-12].
DBBMs, such as Bio-Oss®, are used in the clinic to sup-
port bone grafts in cases of insufficient bone volume at
the host side. Especially the combination of autogenous
bone and DBBM results in accelerated de novo bonee amount of connective tissue (CT) according to the different
Table 3 Mean values and standard deviations of the
three-level score evaluating the amount of connective
tissue (CT) according to the different experiments and
measurements
Measurement Na Mean Standard-deviation
1 Experiment 1 95 2.521 0.536
Experiment 2 24 2.625 0.556
2 Experiment 1 79 1.976 0.674
Experiment 2 18 2.083 0.669
aN = number of specimens.
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et al. in a porcine model [36]. The authors assume this
accelerating effect on bone formation to be due to the
osteoconductive properties of cellular elements trans-
planted with autogenous bone in combination with
DBBM.
Other study groups such as Galindo-Moreno and col-
leagues were able to show the advantages of DBBM in com-
bination with autogenous bone grafts in maxillary sinus
augmentation procedures in a clinical study model [37].
In this study, the healing period was extended up to
16 weeks after surgery compared with previous studies
[29,30].
Considering the amount of vessels in CT and bone,
this study was able to show that the amount of vessels
was at a constant level over time in experiment 2, in
which DBBM and GBR were used to improve the in-
corporation of the graft. This is incongruent with result
of De Marco and associates, who described a moreFigure 6 Graphic illustration of the immunoreactive score (IRS) in the
immunohistochemical staining against vWF according to the differenintensive and more extensive revascularization in the ex-
perimental group in which onlay bone grafts alone were
used [30]. Moreover, the amount of vessels in CT was
higher than in bone at measurement 1 and this ratio was
reversed after a healing period of 12–16 weeks. De
Marco et al. showed that angiogenesis primarily oc-
curred from CT to the graft. Considering that we ex-
tended the healing period up to 16 weeks, whereas De
Marco and colleagues focused on the first 3 weeks after
augmentation, these findings seem to be approximately
equivalent.
We found a statistically significant decrease in the
amount of CT within the bone graft over time in both
experimental groups. Two different reasons for the re-
duced amount of CT in the different groups seem pos-
sible. In experiment 1, which showed a higher rate of
resorption and atrophy in the clinical setting, CT and
bone both decreased simultaneously because of inferior
healing conditions [3,4,21]. For experimental group 2, an
initial competition between regeneration of bone and
the in-growing CT at measurement 1 seems a reasonable
postulate. During the surveillance period of 16 postoper-
ative weeks, revascularization processes in the bone graft
seem to account for the decreased amount of CT, which
is being replaced by newly formed bone.
In the current study, vWF as a marker protein of the
endothelium was used for the immunohistochemical
study of angiogenesis. VWF (factor VIII-related antigen),
synthesized by endothelial cells and megakaryocvytes is
a glycoprotein, that mediates platelet adhesion and stabi-
lizes factor VIII at sites of vascular injury [38]. MoreoverROIs “recipient site”, “bone graft” and “transfer zone” after
t experiments and measurements.
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is commonly used as an immunohistochemical marker
for endothelial cells, stainings for other specific endothe-
lial markers such as CD31, CD34, and Fli-1 should be
performed in future studies to verify the current results
[39]. Nevertheless, the increased expression in the ROI
“recipient site” emphasizes the pattern of revasculariza-
tion from the host site to the bone graft.
The biocompatibility of DBBMs such as Bio-Oss® has
been shown in previous studies [40]. However, the two
cases of infection in this study occured in experiment 2
with the use of a DBBM cover. DBBM is a xenograft ma-
terial and foreign to the body. Although it is deprotei-
nized, others report about low levels of osteoinductive
or immunogenic proteins within the spongiosa granules
[41,42]. In this context, an intense and prolonged im-
mune response seems to be possible. As DBBMs are re-
sorbed slowly, the potential of infection should not be
underestimated. These effects have to be studied in
long-term follow-up clinical trials.
Taking the results of this study and previous studies
into consideration, it seems that the use of a CM in
combination with DBBM in autogenous bone grafts
provides benefits for bone tissue regeneration in terms
of revascularization, reduced resorption and less atrophy
of the graft compared with simple onlay bone grafts
[3,4,21]. The fact that angiogenesis precedes osteogen-
esis and that newly formed bone is always found in close
relation with newly formed vessels, indicates the close
connection of angiogenesis and osteogenesis [43]. If this
is true only because of the protective effects of GBR or
if, and how much, the potential angiogenetic properties
of DBBM also promote this effect has to be investigated
in further studies.Conclusion
This study shows more intensive and extensive revascu-
larization in onlay autogenous iliac grafts for lateral
alveolar ridge augmentation with the use of GBR and
DBBM compared with simple onlay bone grafts.Competing interests
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